← Back to Clinical Trials
Recruiting NCT07278934

NCT07278934 Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07278934
Status Recruiting
Phase
Sponsor New York University
Condition Unaccompanied Migration
Study Type INTERVENTIONAL
Enrollment 1,920 participants
Start Date 2026-04-07
Primary Completion 2030-08-15

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
ANZANSI Family Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,920 participants in total. It began in 2026-04-07 with a primary completion date of 2030-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study seeks to address the urgent need for theoretically and empirically informed interventions that would address the increasing numbers of unaccompanied minors migrating from rural to urban centers in developing countries for better economic opportunities. This process often results in hazardous child labor defined as work that is mentally, physically, socially or morally dangerous and harmful; interfering with schooling and health and mental health functioning, and leading to several other disproportionate risks. Unaccompanied migrant child laborers' vulnerability is further intensified by the lack of parental protection and community belonging in the host urban center. The International Labor Organization (ILO) estimates that 9.6% of children (ages 5 to 17) across the globe are child laborers and draws attention to migrant child laborers as an underreported and highly vulnerable group, a significant portion of which are female with no education. Poverty has been identified as the main driver of child labor, with family context also being a critical contributing factor. Sub-Saharan Africa (SSA) has the highest rates of child labor (24%), with Ghana -the focus of this study- registering one of the highest child labor prevalence at 22%, including unaccompanied child migrant laborers. In Ghana, unaccompanied adolescent girls migrate from the Northern region to urban centers in the south to work in the informal economy. Load carrying is the most common type of labor for this population and exposes migrant girls to multiple developmental and health risks. Building on the recently concluded R21 study (with 97 adolescent girls aged 11 to 14 years and their caregivers) that showed high feasibility and acceptability, and promising preliminary impact of the ANZANSI (resilience in Dagbani -local language) combination intervention in the same region, we propose to test its effectiveness in a larger two-arm cluster randomized clinical trial among 960 adolescent girls (age 11 to 14 years) at risk of school dropout nested within 32 public junior high schools in the Northern region of Ghana and their caregivers. The schools will be randomly assigned to one of two study conditions: 1) ANZANSI (FEE+MFG) and 2) bolstered usual care. The intervention will be delivered for 12 months, with assessments conducted at baseline and at 12-, 24-, and 36-month follow-ups post-intervention initiation. The study specific aims are: Aim 1: Examine the short- and medium-term impacts of ANZANSI intervention on the incidence of unaccompanied migration for child labor (primary outcome), and academic progress and psychosocial outcomes (secondary); Aim 2: Examine the impact of the ANZANSI intervention on potential mechanisms of change at the individual, family, and community levels; Aim 3: Evaluate the cost and cost-effectiveness of each intervention condition; and Aim 4: Qualitatively examine participants, facilitators, and school leadership's experiences with the intervention.

Eligibility Criteria

Inclusion Criteria: Adolescent girls' inclusion criteria are: * Enrolled in school and living within a family (defined broadly -not necessarily biological parents) * Ages 11 to 14 * Skipping school in the past academic term (with at least 10% of unexcused absences). * Capable of giving assent The caregiver inclusion criteria * Age 18 or older * Self-identified as primary caregiver of the adolescent girl * Capable of providing informed consent. Exclusion Criteria: \- Participants that do not meet the criteria or exhibit a lack of understanding of the study procedures and hence not able to provide informed consent will be excluded.

Contact & Investigator

Central Contact

Ozge Sensoy Bahar

✉ osb208@nyu.edu

📞 617 610 6814

Frequently Asked Questions

Who can join the NCT07278934 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, studying Unaccompanied Migration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07278934 currently recruiting?

Yes, NCT07278934 is actively recruiting participants. Contact the research team at osb208@nyu.edu for enrollment information.

Where is the NCT07278934 trial being conducted?

This trial is being conducted at Tamale, Ghana.

Who is sponsoring the NCT07278934 clinical trial?

NCT07278934 is sponsored by New York University. The trial plans to enroll 1,920 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology